Get documents about "Model Standing Orders Amharic (PDF)
Document Sample
¹{ŸQ« eT" ______________________ ¹|JÀ| m"____/____/_____
H¨o{ª* H™+‚1™+1 ™&õH#ª,² vO`ô HQcØ
¡|w| ¹R×]¼ OÖ¾p‚ oé"
Ožzx HQÑw€« ™ªm*¬‚ ›À±&BT HQžzv# JЂ ¨IЂ" H`e¬T GŠ HJϬ O`ô-«Ó
¹™&õH#ª,² ¡|w| ²_ ›ÃcØ ¹QžH¡H# T¡¼}‚ ŸH# HO¨c ¹QžzH#| OÖ¾p‚
¾[ÁJ"" HR“«T ؼm, Ç™¬È ¹QJ OJe v&cÖ# ›`c¬ (¨¾T JϬ) Ožzx ™¾Ñw€«T
RH| I¾G ¾‚IJ"" ›Â¼« wà\ zÛR] ؼm,¬‚ OÖ¹o ¾ÑwJ HRH| x Š«"" ™Å
ؼm, ÓJé ŸJGŠ— Ö¼m,« ›Âx^^J¬| ¹Ö+ wHP¼¬ ¾Ö¾m%""
™¬ ™¾ÀHT ™I«oT
1. ¹Qžzv« c« ²_ {VJ ¨¾?
2. ¹Qžzv« c« H›m%IJ ¨¾T HQcÖ« ¹¡|w ¾±z-ŠÑ`
™HoeRR|/™H`Ì ™H« ¨¾?
3. ¹Qžzv« c« v™&õH#ª,² ¡|w| T¡¼| ¹zŠd
x`z% ™HoeRR|/FOT/™H`Ì ™ÒØU| ¼«nJ ¨¾?
4. ¹Qžzv« c« ¹Ñ&H-w] vh&{ ¾´| ¼«nJ ¨¾?
oç# ¹UI« :___________________________________________ m:_______________
oç# ¹O[O[«:___________________________________________m:_______________
.
Technical content reviewed by the Centers for Disease Control and Prevention. September 2009.
Adapted by MDPH from Screening Questionnaire for Injectable Vaccination from the Immunization Action Coalition (9-
09)--www.immunize.org
Screening Questionnaire for Seasonal and H1N1 Influenza Injectable Vaccination September 2009 (Amharic)
Information for Health Professionals about the Screening Questionnaire
for Seasonal and H1N1 Influenza Injectable Vaccination
Are you interested in knowing why we included a certain question on the Screening
Questionnaire? If so, read the information below. If you want to find out even more, consult the
sources listed at the bottom of this page.
1. Is the person to be vaccinated sick today? 3. Has the person to be vaccinated ever had a
There is no evidence that acute illness reduces serious reaction to influenza vaccine in the
vaccine efficacy or increases vaccine adverse past?
events. Persons with an acute febrile illness usually Patients reporting a serious reaction to a previous
should not be vaccinated until their symptoms have dose of inactivated influenza vaccine should be
improved. Minor illnesses with or without fever do asked to describe their symptoms. Immediate—
not contraindicate use of influenza vaccine. Do not presumably allergic—reactions are usually a
withhold vaccination if a person is taking antibiotics. contraindication to further vaccination against
influenza.
2. Does the person to be vaccinated have an
allergy to eggs or to a component of the Fever, malaise, myalgia, and other systemic
vaccine? symptoms most often affect persons who are first-
Allergic reactions to any vaccine component can time vaccinees. These mild-to-moderate local
occur. The majority of reactions probably are reactions are not a contraindication to future
caused by residual egg protein. Although current vaccination. Also, red eyes or mild upper facial
influenza vaccines contain only a limited quantity of swelling following vaccination with inactivated
egg protein, this protein can induce immediate injectable influenza vaccine is most likely a
allergic reactions among persons who have severe coincidental event and not related to the vaccine;
egg allergy. If a person can eat eggs, they can these persons can receive injectable vaccine
receive inactivated influenza vaccine. However, without further evaluation.
persons who have experienced an anaphylactic
reaction (e.g., hives, swelling of the lips or tongue, 4. Has the person to be vaccinated ever had
acute respiratory distress, or collapse) after eating Guillain-Barré syndrome?
eggs should consult a physician for appropriate It is prudent to avoid vaccinating persons who are
evaluation to help determine if vaccine should be not at high risk for severe influenza complications
administered. Persons who have documented but who are known to have developed Guillain-
immunoglobulin E (IgE)-mediated hypersensitivity Barré syndrome (GBS) within 6 weeks after
to eggs, including those who have had occupational receiving a previous influenza vaccination. As an
asthma or other allergic responses to egg protein, alternative, physicians might consider using
might also be at increased risk for allergic reactions influenza antiviral chemoprophylaxis for these
to influenza vaccine. Consultation with a physician persons. Although data are limited, the established
should be considered. Protocols have been benefits of influenza vaccination for the majority of
published for safely administering influenza vaccine persons who have a history of GBS, and who are at
to persons with egg allergies (see source 3). high risk for severe complications from influenza,
justify yearly vaccination.
FluZone (sanofi pasteur) contains gelatin as a
stabilizer; therefore a history of anaphylactic ______________________
reaction to gelatin is a contraindication. Some Sources:
inactivated influenza vaccines contain thimerosal as
1. CDC. Epidemiology & Prevention of Vaccine-Preventable Diseases,
a preservative. Most persons with sensitivity to WL Atkinson et al., editors, at www.cdc.gov/vaccines/ pubs/pinkbook.
thimerosal, such as that found in contact lens 2. CDC. “General Recommendations on Immunization:
solution, do not experience reactions to thimerosal Recommendations of the Advisory Committee on Immunization
administered as a component of vaccines. Check Practices (ACIP)” at www.cdc.gov/vaccines/pubs/acip-list.htm.
3. CDC. “Prevention and Control of Influenza—Recommendations of
the package insert at www.immunize.org/ ACIP” at www.cdc.gov/flu/professionals/ vaccination.
packageinserts for a list of the vaccine components 4. CDC. “Use of Influenza A (H1N1) 2009 Monovalent Vaccine” at
(i.e., excipients and culture media) used in the http://www.cdc.gov/mmwr/PDF/rr/rr5810.pdf.
production of the vaccine, or go to www.cdc.gov/
vaccines/pubs/pinkbook/downloads/appendices/B/e
xcipient-table-2.pdf.
Adapted by MDPH from Screening Questionnaire for Injectable Vaccination from the Immunization Action Coalition (9-
09)--www.immunize.org
Screening Questionnaire for Seasonal and H1N1 Influenza Injectable Vaccination September 2009 (Amharic)
Related docs
